◆ FUNDING DATA
- Round
- Seed
- Location
- Plano, United States
- Priority score
- 85/100
- Confidence
- 70/100
Niches
Industries
HealthTech
Seed⬢ HOT
Starlight Therapeutics.
Starlight Therapeutics is developing STAR-001, a highly potent, brain-permeable small molecule prodrug with synthetic lethality properties that targets adult and pediatric CNS tumors including glioblastoma, brain metastases, ATRT, and DIPG.